Therapy News and Research

RSS

Study finds increase in number of hypothyroidism patients receiving treatment other than levothyroxine

The use of thyroid hormones other than the commonly prescribed hormone medicine levothyroxine to treat hypothyroidism, or underactive thyroid, is increasing, according to a study being presented Friday at ENDO 2023, the Endocrine Society's annual meeting in Chicago, Ill.

16 Jun 2023

Reform of EU pharmaceutical legislation: Improving access to innovative drugs at the national level

The European Commission's stated aim is to improve access to innovative drugs at the national level throughout the EU.

16 Jun 2023

Creating sustainable health systems viable for the future in Europe

What could healthcare look like in 10, 20, or 30 years? What will be the future of healthcare? Will medical professionals make diagnoses with the aid of artificial intelligence? Will doctors use big data analytics to predict the course of diseases?

16 Jun 2023

Endocrine Society's new Scientific Statement focuses on endocrine-related changes and aging

A new Scientific Statement released today by the Endocrine Society highlights the differences between aspects of aging that are normal and sometimes over-treated, and those such as menopausal symptoms and osteoporosis that can be treated and deserve more attention.

16 Jun 2023

Catalent adds new cryogenic capabilities at Shiga, Japan, facility to support clinical supply demand for cell and gene therapy development

Catalent today announced that it has expanded the services and capabilities at its facility in Shiga, Japan, to include the storage, kitting, and distribution of advanced therapies at ultra-low temperatures for clinical trials.

From Catalent 16 Jun 2023

Catalent expands OneBio® suite for integrated development, manufacturing and supply across biologic modalities

Catalen today announced that it has expanded its integrated development, manufacturing and supply solution, OneBio® Suite, across a range of biologic modalities, including antibody and recombinant proteins, cell and gene therapies, and mRNA.

From Catalent 16 Jun 2023

New research finds most women diagnosed with early breast cancer can expect to become long-term survivors

Researchers reported longitudinal outcomes among British women suffering from early invasive-type breast tumors as their initial tumor and those initially treated by surgical methods such as conservative surgery or mastectomy.

16 Jun 2023

Is maternal obsessive-compulsive disorder associated with adverse pregnancy, delivery, and neonatal outcomes?

Researchers assessed the correlation between maternal OCD and pregnancy outcomes.

16 Jun 2023

$Fruquintinib improved survival in patients with refractory metastatic colorectal cancer$

Fruquintinib improved survival in patients with refractory metastatic colorectal cancer

Researchers from The University of Texas MD Anderson Cancer Center reported study results showing that the targeted therapy fruquintinib significantly improved overall survival (OS) and progression-free survival (PFS) in patients with refractory metastatic colorectal cancer.

16 Jun 2023

No improvement in freedom from progression rates for patients: Study

Results from the NRG Oncology NRG-RTOG 0232 clinical trial adding external beam radiotherapy (EBRT) to brachytherapy (BT) in men with intermediate-risk prostate cancer indicate that there was no improvement in freedom from progression (FFP) rates for patients.

16 Jun 2023

New selective targeted therapy for metastatic colorectal cancer prolongs overall survival

A new therapy is on the horizon for patients with metastatic colorectal cancer who have run out of treatment options.

16 Jun 2023

$11.7M from Department of Defense to fund research on discovering a treatment for hydrocephalus

Researchers at the School of Science at IUPUI will lead two grants totaling $11.7 million from the U.S. Department of Defense to fund research on discovering a drug treatment for hydrocephalus, a condition commonly associated with complications from traumatic brain injury that causes cerebrospinal fluid to accumulate in the brain.

15 Jun 2023

Destroying the tether of shattered chromosomal fragments may help prevent cancerous mutations

Healthy cells work hard to maintain the integrity of our DNA, but occasionally, a chromosome can get separated from the others and break apart during cell division.

15 Jun 2023

$1.9 million grant awarded to explore the effect of antifungal drugs in Crohn's patients

Dr. Iliyan D. Iliev, an associate professor of immunology in medicine in the Division of Gastroenterology and Hepatology, co-director of the Microbiome Core and a member of the Jill Roberts Institute for Research in Inflammatory Bowel Disease (IBD) at Weill Cornell Medicine, is the lead investigator on a grant to Weill Cornell Medicine from The Leona M. and Harry B. Helmsley Charitable Trust to target pathogenic fungi in patients with Crohn's disease.

15 Jun 2023

Bempedoic acid may offer an alternative to the popular cholesterol-lowering drugs

A medication called bempedoic acid reduced the risk of cardiac events as well as statins and may offer an alternative to the popular cholesterol-reducing medications, according to industry-supported research being presented Thursday at ENDO 2023, the Endocrine Society's annual meeting, in Chicago, Ill.

15 Jun 2023

New approach improves diagnosis of limb-girdle muscular dystrophy

It's not easy to distinguish between the dozens of subtypes of limb girdle muscular dystrophy - a rare, genetic muscle disease characterized by weakness in the hips and shoulders that causes difficulty walking and lifting the arms.

15 Jun 2023

Review: Pathophysiology, diagnosis and management of carcinoid heart disease

Announcing a new article publication for Cardiovascular Innovations and Applications journal.

15 Jun 2023

Promising emerging treatment for cardiac arrest patients yields similar results to targeted standard care

A promising emerging treatment (hypercapnia) for comatose adult cardiac arrest patients has been found to yield similar results to current treatment, in a new study published today in the prestigious medical journal New England Journal of Medicine.

15 Jun 2023

$Study: Hip fracture cases estimated to nearly double by 2050$

Study: Hip fracture cases estimated to nearly double by 2050

An international group of researchers led by the Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, the University of Hong Kong (HKUMed), and including Douglas P Kiel, MD, MPH, Director Musculoskeletal Research Center, Marcus Institute for Aging Research, Hebrew SeniorLife, and Professor of Medicine, Harvard Medical School, evaluated the secular trends in hip fracture incidence, treatment patterns following a hip fracture, and all-cause mortality in 19 countries and regions from 2005 to 2018.

15 Jun 2023

Routine testing may help to reduce health disparities for people with peripheral artery disease

Low-cost, routine testing may help to reduce disparities and health care costs for people with peripheral artery disease (PAD), according to a new scientific statement from the American Heart Association, published today in the Association's flagship peer-reviewed journal Circulation.

15 Jun 2023

Therapy News and Research

Study finds increase in number of hypothyroidism patients receiving treatment other than levothyroxine

Reform of EU pharmaceutical legislation: Improving access to innovative drugs at the national level

Creating sustainable health systems viable for the future in Europe

Endocrine Society's new Scientific Statement focuses on endocrine-related changes and aging

Catalent adds new cryogenic capabilities at Shiga, Japan, facility to support clinical supply demand for cell and gene therapy development

Catalent expands OneBio® suite for integrated development, manufacturing and supply across biologic modalities

New research finds most women diagnosed with early breast cancer can expect to become long-term survivors

Is maternal obsessive-compulsive disorder associated with adverse pregnancy, delivery, and neonatal outcomes?

Fruquintinib improved survival in patients with refractory metastatic colorectal cancer

No improvement in freedom from progression rates for patients: Study

New selective targeted therapy for metastatic colorectal cancer prolongs overall survival

$11.7M from Department of Defense to fund research on discovering a treatment for hydrocephalus

Destroying the tether of shattered chromosomal fragments may help prevent cancerous mutations

$1.9 million grant awarded to explore the effect of antifungal drugs in Crohn's patients

Bempedoic acid may offer an alternative to the popular cholesterol-lowering drugs

New approach improves diagnosis of limb-girdle muscular dystrophy

Review: Pathophysiology, diagnosis and management of carcinoid heart disease

Promising emerging treatment for cardiac arrest patients yields similar results to targeted standard care

Study: Hip fracture cases estimated to nearly double by 2050

Routine testing may help to reduce health disparities for people with peripheral artery disease

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News